Skip to news
JQJO
Latest

Weight-Loss Drugs Affect Medical Imaging Scans | JQJO

Weight-Loss Drugs Affect Medical Imaging Scans

Weight-Loss Drugs Affect Medical Imaging Scans

Tap title to read story

0:00 / 0:38

Popular GLP-1 weight-loss drugs may be interfering with critical PET-CT scans, potentially leading to delayed diagnoses or unnecessary procedures. Research indicates these medications can cause unusual "hot spots" on scans, masking diseases like cancer or making healthy tissue appear abnormal. Doctors urge imaging teams to document patients' medication histories to aid scan interpretation while formal guidelines are developed. Experts advise against stopping GLP-1s before scans, emphasizing the need for accurate diagnosis.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Celtics Lose After Ref Controversy

Tap title to read story

0:00 / 0:00

Mammoth End Six‑Game Slide

Tap title to read story

0:00 / 0:00

JQJO

Find your next story

Search JQJO’s current coverage.